CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis
Authors
Joseph Caprini
Lauren Cote
+6 more
Steven Greenberg
Francisco Jose Munoz
Lisa Baumann Kreuziger
Manuel Monreal Bosch
Reina Valle
Peter Verhamme
Publication date
1 January 2015
Publisher
'Elsevier BV'
Doi
Abstract
BACKGROUND: Few studies have investigated the treatment and the outcomes of patients with catheter-related thrombosis (CRT). METHODS: The RIETE registry (Registro Informatizado de Enfermedad TromboEmbólica [Computerized Registry of Patients with Venous Thromboembolism]) is a prospective international registry of consecutive patients with objectively confirmed venous thromboembolism (VTE). We analyzed the characteristics, treatment, and outcomes of patients with CRT. RESULTS: Of 558 patients with CRT, 45 (8%) presented with a pulmonary embolism (PE) concomitantly. More patients had central line-associated thrombosis compared with port systems, but catheter type did not influence the risk of presenting with a PE. Patients with only CRT were more often prescribed low-molecular-weight heparin for the duration of their anticoagulant treatment compared with patients presenting with concomitant PE. VTE recurrences and major bleeding events occurred frequently during treatment with anticoagulation (7 per 100 patient-years and 8.9 per 100 patient years, respectively). The rates of fatal PE recurrences (1.85 per 100 patient-years) and fatal bleeding (2.32 per 100 patient-years) were similar. Patients with an additional transient risk factor for VTE had the lowest risk for VTE recurrences (odds ratio [OR], 0.07; 90% confidence interval [CI], 0.01-0.45) compared with patients with CRT and no additional transient risk factors. PE at presentation increased the risk of recurrent thrombosis by 2.4 times. Renal insufficiency was also an independent predictor of recurrent thrombosis (OR, 3.93; 90% CI, 2.0-7.7). The odds of recurrent thrombosis was decreased by 77% in patients who received anticoagulation therapy for >90 days compared with patients with a shorter treatment (OR, 0.23; 90% CI, 0.1-0.56). CONCLUSIONS: Concomitant PE occurs less frequently in CRT than lower extremity deep venous thrombosis, but it is associated with a worse outcome. CRT occurs in high-risk patients, and duration of anticoagulation must be predicated on balancing these risks.publisher: Elsevier articletitle: A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis journaltitle: Journal of Vascular Surgery: Venous and Lymphatic Disorders articlelink: http://dx.doi.org/10.1016/j.jvsv.2015.03.002 content_type: article copyright: Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.status: publishe
Similar works
Full text
Available Versions
Lirias
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lirias2repo.kuleuven.be:12...
Last time updated on 10/12/2019